{
    "Trade/Device Name(s)": [
        "Simplexa HSV 1 & 2 Direct",
        "Simplexa HSV 1 & 2 Positive Control Pack"
    ],
    "Submitter Information": "DiaSorin Molecular LLC",
    "510(k) Number": "K173798",
    "Predicate Device Reference 510(k) Number(s)": [
        "K133448",
        "K150962"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PGI"
    ],
    "Summary Letter Date": "December 12, 2017",
    "Summary Letter Received Date": "December 14, 2017",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3309"
    ],
    "Regulation Name(s)": [
        "Herpes Virus Nucleic Acid-Based Cutaneous and Mucocutaneous Lesion Panel"
    ],
    "Analyte Class(es)": [
        "virology",
        "genetic molecular"
    ],
    "Analyte(s)": [
        "Herpes simplex virus 1 (HSV-1)",
        "Herpes simplex virus 2 (HSV-2)"
    ],
    "Specimen Type(s)": [
        "Cutaneous lesion swab",
        "Mucocutaneous lesion swab"
    ],
    "Specimen Container(s)": [
        "Swab transport media (BD VTM, M4, M4RT, M5, M6, UTM)"
    ],
    "Instrument(s)/Platform(s)": [
        "LIAISON MDX instrument",
        "LIAISON MDX Studio Software",
        "Direct Amplification Disc"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time PCR",
        "Bi-functional fluorescent probe-primers"
    ],
    "Methodologies": [
        "PCR-based qualitative DNA detection",
        "Molecular differentiation"
    ],
    "Submission Type(s)": [
        "Assay",
        "Control",
        "Kit",
        "Reagent",
        "Accessory",
        "Disc"
    ],
    "Document Summary": "FDA 510(k) summary for DiaSorin Molecular Simplexa HSV 1 & 2 Direct and Positive Control Pack for qualitative real-time PCR detection and differentiation of HSV-1 and HSV-2 DNA from lesion swabs",
    "Indications for Use Summary": "Qualitative detection and differentiation of HSV-1 and HSV-2 DNA in mucocutaneous and cutaneous lesion swabs from symptomatic patients, as an aid in the differential diagnosis of HSV-1 and HSV-2 infections; Positive Control Pack for use as assay control",
    "fda_folder": "Microbiology"
}